tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
NRX Pharmaceuticals Gains FDA Approval for KETAFREE™
PremiumCompany AnnouncementsNRX Pharmaceuticals Gains FDA Approval for KETAFREE™
14d ago
NRx Pharmaceuticals (NASDAQ: NRXP) Receives FDA Approval of Suitability Petition for Preservative-Free Ketamine Product
Premium
TipRanks Newswire
NRx Pharmaceuticals (NASDAQ: NRXP) Receives FDA Approval of Suitability Petition for Preservative-Free Ketamine Product
15d ago
NRx receives notification from FDA that Suitability Petition has been granted
Premium
The Fly
NRx receives notification from FDA that Suitability Petition has been granted
16d ago
NRx Pharmaceuticals, HOPE Therapeutics complete Dura Medical acquisition
PremiumThe FlyNRx Pharmaceuticals, HOPE Therapeutics complete Dura Medical acquisition
1M ago
NRx Pharmaceuticals initiated with a Buy at H.C. Wainwright
Premium
The Fly
NRx Pharmaceuticals initiated with a Buy at H.C. Wainwright
1M ago
NRx Pharmaceuticals (NASDAQ: NRXP) Secures FDA Fast Track for IV Ketamine Formulation NRX-100 in Suicidal Depression
Premium
TipRanks Newswire
NRx Pharmaceuticals (NASDAQ: NRXP) Secures FDA Fast Track for IV Ketamine Formulation NRX-100 in Suicidal Depression
1M ago
NRx Pharmaceuticals (NASDAQ: NRXP) Seeks FDA Ban on Toxic Ketamine Preservative
PremiumTipRanks NewswireNRx Pharmaceuticals (NASDAQ: NRXP) Seeks FDA Ban on Toxic Ketamine Preservative
2M ago
NRx Pharmaceuticals price target raised to $25 from $21 at BTIG
Premium
The Fly
NRx Pharmaceuticals price target raised to $25 from $21 at BTIG
2M ago
Psychedelic: NRx Pharmaceuticals reports Q2 earnings
Premium
The Fly
Psychedelic: NRx Pharmaceuticals reports Q2 earnings
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100